Drugdiscovery >> Pharmaceutical Companies >> News
5451
Views
Isis shares climbe after positive results from its spinal muscular atrophy drug study - drugdiscovery.com
Isis shares climbe after positive results from its spinal muscular atrophy drug study - drugdiscovery.com


Isis Pharmaceuticals drug designed to treat spinal muscular atrophy showed success in a mid- stage study. This announcement led to a raise of company’s shares.
Read More >>


Tags: news, Isis Pharmaceutical, spinal muscular atrophy, clinical trial, shares, experimental drug - September 23, 2013
Related Articles
2241
Views
Novartis has announced the results of phase 4 INSTEAD study Novartis has announced the results of phase 4 INSTEAD study
Novartis has announced the result of a Phase 4 INSTEAD research made to imporve its new COPD drug. Once-daily indacaterol has shown very promising data. Read More >>

Tags: durg development, INSTEAD Swift study, GSK, Novartis, pharmaceutical news, pharmaceutical companies

3962
Views
Biogen – Isis new collaboration Biogen – Isis new collaboration
Biogen Idec and Isis Pharmaceuticals have entered into a broad, six-year collaboration aiming to develop new therapies to treat neurological disorders. Read More >>

Tags: Biogen, Isis, collaboration, neurological disorders, therapy

3192
Views
Catalyst Pharmaceutical shares rise Catalyst Pharmaceutical shares rise
After analyst’s good prognosis for the drug Firdapse, the company’s shares rose. Firdapse is intended to be used as a treatment for a rare autoimmune disease called Lambert-Eaton Myasthenic Syndr Read More >>

Tags: Catalyst Pharmaceutical, shares, Firdapse

4746
Views
Agenus shares fall after GSK’s MAGE-A3 failure in a Phase 3 trial Agenus shares fall after GSK’s MAGE-A3 failure in a Phase 3 trial
Glaxo’s MAGE-A3 immunotherapy treatment includes Agenus' SQ-21 Stimulon vaccine adjuvant which is designed to make drugs more effective. GSK reported that MAGE-A3 failed to meet its first goal in a Read More >>

Tags: Agenus, shares, GSK, melanoma clinical trial, MAGE-A3, SQ-21 Stimulon vaccine adjuvant, vaccine adjuvant

1524
Views
Neumedicines ha a new Phase I study Neumedicines ha a new Phase I study
Neumedicines announced that their proposal to conduct a Phase I clinical study of recombinant human interleukin-12 (rHuIL-12) for the treatment of traumatic wounds has been recommended for funding sub Read More >>

Tags: Neumedicines, phase I study, phase I clinical trial, drugresearch, drug discovery

3069
Views
Rockwell’s anemia drug successful in a second late-stage clinical trial Rockwell’s anemia drug successful in a second late-stage clinical trial
Rockwell Medical reported successful results of its experimental anemia drug - SFP, or soluble ferric phosphate, in a second late-stage clinical trial. Small, frequent doses of SFP proved to be safer Read More >>

Tags: Rockwell Medical, rockwell, anemia drug, SFP, soluble ferric phosphate, clinical trial, shares

3149
Views
Jazz Pharmaceuticals is combined with Gentium Jazz Pharmaceuticals is combined with Gentium
Jazz Pharmaceuticals has signed a contract with Gentium. Jazz Pharmaceuticals will make a cash tender offer of $57.00 per share for all outstanding Gentium ordinary shares and American Depositary Shar Read More >>

Tags: depositary Shares, Gentium, Jazz Pharmaceuticals

3346
Views
4-in-1 Vaccine of Astra Zeneca gets Positive Echo 4-in-1 Vaccine of Astra Zeneca gets Positive Echo
Astra Zeneca'n new vaccine prevents influenza A and B viruses. It covers 2 chains of the B virus, and it can be more effective than any vaccines on the market. Read More >>

Tags: Astra Zeneca, Virus, h1n1, influenza

1664
Views
Pharmaceutical companies team up to deal with Pharmaceutical companies team up to deal with "big data challenge"
Cancer Research UK says it teams up with other oharmaceutical and technical companies to solve the big data problems. huge amounts of DATA received from studies is going to be analyzed now. Read More >>

Tags: DATA, analisys, study, big data, cancer research, big data cancer research, Cancer research UK

3718
Views
New Drug Applications of Gilead was Accepted by FDA New Drug Applications of Gilead was Accepted by FDA
Gilead has announced that its new drug application was accepted by FDA. The new drug is going to be a novel HIV treatment. Read More >>

Tags: drug, drug development, FDA, HIV drug, Gilead, aids drug

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013